| Literature DB >> 29577545 |
Junhui Zhou1, Guoming Wang1,2, Zhongchi Liu1.
Abstract
The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system is an effective genome editing tool for plant and animal genomes. However, there are still few reports on the successful application of CRISPR-Cas9 to horticultural plants, especially with regard to germ-line transmission of targeted mutations. Here, we report high-efficiency genome editing in the wild strawberry Fragaria vesca and its successful application to mutate the auxin biosynthesis gene TAA1 and auxin response factor 8 (ARF8). In our CRISPR system, the Arabidopsis U6 promoter AtU6-26 and the wild strawberry U6 promoter FveU6-2 were each used to drive the expression of sgRNA, and both promoters were shown to lead to high-efficiency genome editing in strawberry. To test germ-line transmission of the edited mutations and new mutations induced in the next generation, the progeny of the primary (T0) transgenic plants carrying the CRISPR construct was analysed. New mutations were detected in the progeny plants at a high efficiency, including large deletions between the two PAM sites. Further, T1 plants harbouring arf8 homozygous knockout mutations grew considerably faster than wild-type plants. The results indicate that our CRISPR vectors can be used to edit the wild strawberry genome at a high efficiency and that both sgRNA design and appropriate U6 promoters contribute to the success of genomic editing. Our results open up exciting opportunities for engineering strawberry and related horticultural crops to improve traits of economic importance.Entities:
Keywords: CRISPR; auxin; high efficiency; inheritance; strawberry; vector development
Mesh:
Year: 2018 PMID: 29577545 PMCID: PMC6181217 DOI: 10.1111/pbi.12922
Source DB: PubMed Journal: Plant Biotechnol J ISSN: 1467-7644 Impact factor: 9.803
Figure 1Diagrams illustrating gateway‐based CRISPR vectors. (a) Illustration of the single sgRNA gateway entry vector JH1. A sgRNA cloning cassette (enlarged on top) is inserted between the attL1 and attL2 recombination sites of pENTR2b. Two inverted BsaI restriction enzyme recognition sites enable easy cloning of the double‐stranded target sequence. pENTR2b‐R and pENTR2b‐F in the vector map are two sequencing primers. (b) Illustration of the dual sgRNA gateway entry vector JH4. The dual sgRNA cloning cassette (enlarged on top) is inserted between the attL1 and attL2 recombination sites of pENTR2b. One sgRNA is driven by the FveU6‐2 promoter similarly to JH1. The second sgRNA is driven by the Arabidopsis U6‐26 promoter. A linker sequence GCGCTTCAAGGTGCACATGG between the AtU6‐26 promoter and the sgRNA scaffold can be replaced with a 20 bp target sequence using the Q5 site‐directed mutagenesis kit. (c) The gateway destination vector JH12 is a hygromycin‐resistant binary vector harbouring a AtUBQ10 promoter‐driven Cas9. (d) The gateway destination vector JH19, a binary vector similar to JH12 except that JH19, harbours a 35S::NSL‐3XGFP cassette. The GFP fluorescence allows easy visualization and identification of transgenic plants.
Figure 2Analyses of T0 wild strawberry plants carrying CRISPR constructs revealed mutations in Fve and Fve genes. (a) PCR genotyping results of T0 transgenic plants harbouring the construct. The presence of Cas9 PCR product is shown. (b) PCR genotyping results of T0 transgenic plants harbouring the construct. The presence of Cas9 (top row) and sgRNA (lower row) in these transgenic plants is shown by the PCR bands. (c) Sequencing of PCR products revealed the presence of mutations in the Fve gene, more abundantly around the PAM1 (TGG) site. Individual transgenic plants are named with a number shown to the left. 11/23/26 refer to three different plants having the same genotype. All mutations exist as heterozygous. (d) Sequencing of PCR products revealed the presence of mutations in the Fve gene at the PAM2 (TGG) site only. Individual plant names (numbers) are to the left of the sequence. Mutations exist as heterozygous, homozygous or biallelic.
Summary of genotyping results in T0 transgenic lines
| Gene name and plant no. | Line no. | Genotype | PAM site | Confirmation method | Notes |
|---|---|---|---|---|---|
| JH19‐ | Line 5 | (0, −1a) | PAM1(340 bp) | Sequencing | |
| JH19‐ | Line 207 | NA | PAM2(470 bp) | Sequencing | |
| JH19‐ | Line 208 | NA | PAM2(470 bp) | Sequencing | |
| JH19‐ | Line 208 | NA | PAM1(340 bp) | Sequencing | Mismatch starts 240 bp upstream of PAM1 |
| JH19‐ | Line 208 | NA | PAM2(470 bp) | Sequencing | |
| JH19‐ | Line 5 | (0, −1a) | PAM1(340 bp) | Sequencing | Figure |
| JH19‐ | Line 17 | (0, 1a) | PAM2(470 bp) | Sequencing | Figure |
| JH19‐ | Line 209 | NA | PAM2(470 bp) | Sequencing | |
| JH19‐ | Line 35 | (0, −1a+1S) | PAM1(340 bp) | Sequencing | Figure |
| JH19‐ | Line 8 | NA | PAM1(340 bp) | Sequencing | |
| JH19‐ | Line 39 | (0, −1a) | PAM1(340 bp) | Sequencing | |
| JH19‐ | Line 109 | NA | PAM2(470 bp) | Sequencing | |
| JH19‐ | Line 7 | (0, −1a) | PAM1(340 bp) | Sequencing | Figure |
| JH19‐ | Line 200 | NA | PAM2(470 bp) | Sequencing | |
| JH19‐ | Line 5 | NA | PAM1(340 bp) | Sequencing | |
| JH19‐ | Line 6 | NA | PAM1(340 bp) | Sequencing | |
| JH19‐ | Line 8 | (0, −1b) | PAM1(340 bp) | Sequencing | Figure |
| JH19‐ | Line 102 | (−2, −3) | PAM2(360 bp) | Sequencing | Figure |
| JH19‐ | Line 102 | (0, −2) | PAM2(360 bp) | Sequencing | Figure |
| JH19‐ | Line 15 | (0, −4) | PAM2(360 bp) | Sequencing | Figure |
| JH19‐ | Line 15 | (−2, −2) | PAM2(360 bp) | Sequencing | |
| JH19‐ | Line 1 | (0, −2) | PAM2(360 bp) | Sequencing | |
| JH19‐ | Line 103 | (−2, −2) | PAM2(360 bp) | Sequencing | Figure |
| JH19‐ | Line 19 | (−2, −11 + 1S) | PAM2(360 bp) | Sequencing | Figure |
| JH19‐ | Line 19 | (−2, −2) | PAM2(360 bp) | Sequencing | Figure |
| JH19‐ | Line 13 | NA | PAM2(360 bp) | Sequencing | Large fragment deletion |
| JH19‐ | Line 1 | NA | PAM1(340 bp) | Sequencing | Mismatch starts 140 bp upstream of PAM1 |
| JH19‐ | Line 13 | NA | PAM1(340 bp) | Sequencing | Mismatch starts 150 bp upstream of PAM1 |
| JH19‐ | Line 7 | (−2, −2) | PAM2(360 bp) | Sequencing | |
| JH19‐ | Line 7 | (−2, −2) | PAM2(360 bp) | Sequencing | |
| JH19‐ | Line 29 | NA | PAM2(360 bp) | Sequencing | |
| JH19‐ | Line 23 | (0, −1 + 1S) | PAM2(360 bp) | Sequencing | 1 bp deletion and 1 bp substitution |
− sign indicates deletion, 0 indicates no change. −1a, −1b refer to different 1 bp deletion alleles. 1S stands for single base substitution. NA: sequencing results are too complex to resolve, usually due to genetic mosaics and multiple alleles.
Summary of genotyping results in T1 plants
| Gene name and plant no. | New mutation | Genotype | PAM site | Cas9 | Notes |
|---|---|---|---|---|---|
| JH19‐ | NO | (−1a, −110) | PAM1&PAM2 | + | Three sequencing peaks suggesting mosaic; Figure |
| JH19‐ | NO | (−1a, −110) | PAM1&PAM2 | + | Figure |
| JH19‐ | YES | (−1c, −110) | PAM1&PAM2 | + | Figure |
| JH19‐ | NO | (−1a, −1a) | PAM1 | + | |
| JH19‐ | YES | (0, −1a) | PAM1 | + | |
| JH19‐ | NO | (0, 0) | NA | + | |
| JH19‐ | YES | (−110, −110) | PAM1&PAM2 | + | Figure |
| JH19‐ | YES | NA | PAM1 | + | Multiple peaks |
| JH19‐ | YES | (−110, −110) | PAM1&PAM2 | + | Figure |
| JH19‐ | YES | (−1a, −110) | PAM1&PAM2 | + | Multiple peaks (mosaic); Figure |
| JH19‐ | YES | (−1a, −110/+1) | PAM1&PAM2 | + | 110 bp deletion between PAM1 and PAM2 plus +1 (Figure |
| JH19‐ | YES | (−1a, −110/+1) | PAM1&PAM2 | + | Same as JH19‐ |
| JH19‐ | NO | (−1a, −1a) | PAM1 | − | |
| JH19‐ | NO | (−2a, −2a) | PAM2 | − | Figure |
| JH19‐ | YES | NA | PAM2 | − | Multiple peaks |
| JH19‐ | NO | (−2a, −2a) | PAM2 | + | Figure |
| JH19‐ | NO | (0, −2a) | PAM2 | + | |
| JH19‐ | YES | (−2a, −7) | PAM2 | + | Figures |
| JH19‐ | NO | (0, −2a) | PAM2 | − | |
| JH19‐ | NO | (0, −2a) | PAM2 | + | |
| JH19‐ | NO | (0, −2a) | PAM2 | − | |
| JH19‐ | NO | (0, −2a) | PAM2 | ‐ | |
| JH19‐ | YES | (0, −37) | PAM2 | + | Figure |
| JH19‐ | NO | (−2a, −2a) | PAM2 | − | Figures |
| JH19‐ | YES | (0, −2a) | PAM2 | + | |
| JH19‐ | NO | (−2a, −2a) | PAM2 | + | Figures |
| JH19‐ | NO | (0, −2a) | PAM2 | + | |
| JH19‐ | NO | (0, −2a) | PAM2 | − | |
| JH19‐ | NO | (0, 0) | PAM2 | − | |
| JH19‐ | NO | (0, −2a) | PAM2 | + | |
| JH19‐ | YES | (−2b, −5) | PAM2 | + | −5 = ‘−4 and −1’ (Figure |
| JH19‐ | YES | (0, −2 + 1S) | PAM2 | + | |
| JH19‐ | YES | (0, −32) | PAM2 | + | Figure |
NA: multiple peaks that are hard to resolve, likely caused by multiple mutations in different cells or due to polyploidy. −1a, −1b and −1c refer to different alleles of TAA1. −2a and −2b refer to different alleles of ARF8.
Figure 3Genome editing continues at a high frequency in the T1 generation. (a) PCR gel image illustrating the presence of Cas9 transgene in 12 of the 13 T1 plants. All 13 are the self‐progeny of T0 plant #11 (T0‐11). + and – are respective positive and negative PCR controls. (b) PCR gel showing the presence of a −110 bp deletion in some of the T1 plants. Plant 7 and 9 are homozygous for this deletion. T0‐11 (the T0 generation parent plant) and WT nontransgenic plant are shown as negative controls. (c) Illustration of mutations detected in T1 plants. T0‐11 is the genotype of the T0 parent plant. Newly induced mutations (absent from T0‐11) are marked red including two large fragment deletions between the two PAM sites in plants T1‐3 and T1‐11 and T1‐12. (d) Transmission of the transgene (gel image) and mutations detected in the T1 plants derived from T0 plant #66 (T0‐66) or #72 (T0‐72). Newly induced mutations are marked in red.
Figure 4arf8 mutants showed faster seedling growth. (a) Young T1 plants germinated and grown in the same §‐strength MS medium at the same time. The three young plants are siblings derived from T0 plant #11, but differ in genotype (indicated beneath each plant). All three young plants look similar, suggesting that the homozygous mutation (far right) did not cause any obvious phenotype. (b) Six T1 seedlings derived from the same T0 plant #72. Homozygous or biallelic mutant seedlings (top row) all appear larger in size than the seedlings heterozygous for the afr8 mutation (bottom row). All seedlings shown were germinated at the same time and grown in the same §‐strength MS medium. (c) T1 seedlings derived from a different T0 mother plant #66. Seedlings harbouring homozygous or biallelic mutations (top row) all appear larger in size than the seedlings that are wild type in genotype (bottom row). WT: YW5AF7